Sonora Investment Management’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-400
| Closed | -$10K | – | 1120 |
|
|
2021
Q1 | $10K | Hold |
400
| – | – | ﹤0.01% | 1305 |
|
|
2020
Q4 | $6K | Hold |
400
| – | – | ﹤0.01% | 1414 |
|
|
2020
Q3 | $6K | Hold |
400
| – | – | ﹤0.01% | 1410 |
|
|
2020
Q2 | $6K | Hold |
400
| – | – | ﹤0.01% | 1308 |
|
|
2020
Q1 | $2K | Hold |
400
| – | – | ﹤0.01% | 1519 |
|
|
2019
Q4 | $2K | Hold |
400
| – | – | ﹤0.01% | 1599 |
|
|
2019
Q3 | $2K | Hold |
400
| – | – | ﹤0.01% | 1581 |
|
|
2019
Q2 | $3K | Hold |
400
| – | – | ﹤0.01% | 1534 |
|
|
2019
Q1 | $3K | Hold |
400
| – | – | ﹤0.01% | 1359 |
|
|
2018
Q4 | $2K | Hold |
400
| – | – | ﹤0.01% | 1160 |
|
|
2018
Q3 | $3K | Hold |
400
| – | – | ﹤0.01% | 1099 |
|
|
2018
Q2 | $3K | Hold |
400
| – | – | ﹤0.01% | 1046 |
|
|
2018
Q1 | $2.18K | Hold |
400
| – | – | ﹤0.01% | 1048 |
|
|
2017
Q4 | $1.67K | Hold |
400
| – | – | ﹤0.01% | 1092 |
|
|
2017
Q3 | $3.85K | Hold |
400
| – | – | ﹤0.01% | 900 |
|
|
2017
Q2 | $4.73K | Hold |
400
| – | – | ﹤0.01% | 848 |
|
|
2017
Q1 | $5.13K | Hold |
400
| – | – | ﹤0.01% | 792 |
|
|
2016
Q4 | $4.9K | Hold |
400
| – | – | ﹤0.01% | 713 |
|
|
2016
Q3 | $4.72K | Hold |
400
| – | – | ﹤0.01% | 694 |
|
|
2016
Q2 | $3.48K | Hold |
400
| – | – | ﹤0.01% | 734 |
|
|
2016
Q1 | $2.54K | Hold |
400
| – | – | ﹤0.01% | 816 |
|
|
2015
Q4 | $3K | Hold |
400
| – | – | ﹤0.01% | 696 |
|
|
2015
Q3 | $4K | Buy |
+400
| New | +$3.7K | ﹤0.01% | 838 |
|
Sonora Investment Management's GNMK Position: Q2 2021 in Review
Sonora Investment Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 400 shares — an estimated $10K sold.
Sonora Investment Management first reported a position in GNMK in Q3 2015 and held it in 23 quarters. The position peaked at $10K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Sonora Investment Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Sonora Investment Management sold 400 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $10K.
- Sonora Investment Management first reported a position in GenMark Diagnostics, Inc in Q3 2015 and held it in 23 quarters.
- Sonora Investment Management's GenMark Diagnostics, Inc position peaked at $10K in Q1 2021.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Sonora Investment Management's 13F filing for Q2 2021, filed 20 Oct 2021.